TRX-E-009-1

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTRX-E-009-1
Drug Alias NameTrilexiumsuper benzopyrans (CanTx)super benzopyrans (Novogen)super benzopyrans (Triaxial)Trx-1 (Novogen/CanTx) +[9] 
ClassificationSmall molecules
Mechanisms of ActionAnticancer multidrug resistance inhibitorsStem cells inhibitors
TargetsUpdating
Therapy Area/IndicationsOvarian NeoplasmsGlioblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTriaxial Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTriaxial PharmaceuticalsCanTx IncHeaton-Brown Life Sciences +[5] 
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsGlioblastomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A